Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA) - PubMed (original) (raw)
Review
Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)
E Hernlund et al. Arch Osteoporos. 2013.
Abstract
This report describes the epidemiology, burden, and treatment of osteoporosis in the 27 countries of the European Union (EU27).
Introduction: Osteoporosis is characterized by reduced bone mass and disruption of bone architecture, resulting in increased risk of fragility fractures which represent the main clinical consequence of the disease. Fragility fractures are associated with substantial pain and suffering, disability and even death for affected patients and substantial costs to society. The aim of this report was to characterize the burden of osteoporosis in the EU27 in 2010 and beyond.
Methods: The literature on fracture incidence and costs of fractures in the EU27 was reviewed and incorporated into a model estimating the clinical and economic burden of osteoporotic fractures in 2010.
Results: Twenty-two million women and 5.5 million men were estimated to have osteoporosis; and 3.5 million new fragility fractures were sustained, comprising 610,000 hip fractures, 520,000 vertebral fractures, 560,000 forearm fractures and 1,800,000 other fractures (i.e. fractures of the pelvis, rib, humerus, tibia, fibula, clavicle, scapula, sternum and other femoral fractures). The economic burden of incident and prior fragility fractures was estimated at 37 billion. Incident fractures represented 66 % of this cost, long-term fracture care 29 % and pharmacological prevention 5 %. Previous and incident fractures also accounted for 1,180,000 quality-adjusted life years lost during 2010. The costs are expected to increase by 25 % in 2025. The majority of individuals who have sustained an osteoporosis-related fracture or who are at high risk of fracture are untreated and the number of patients on treatment is declining.
Conclusions: In spite of the high social and economic cost of osteoporosis, a substantial treatment gap and projected increase of the economic burden driven by the aging populations, the use of pharmacological interventions to prevent fractures has decreased in recent years, suggesting that a change in healthcare policy is warranted.
Similar articles
- Osteoporosis in the European Union: a compendium of country-specific reports.
Svedbom A, Hernlund E, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA; EU Review Panel of IOF. Svedbom A, et al. Arch Osteoporos. 2013;8(1):137. doi: 10.1007/s11657-013-0137-0. Epub 2013 Oct 11. Arch Osteoporos. 2013. PMID: 24113838 Free PMC article. Review. - Epidemiology and economic burden of osteoporosis in Switzerland.
Svedbom A, Ivergård M, Hernlund E, Rizzoli R, Kanis JA. Svedbom A, et al. Arch Osteoporos. 2014;9:187. doi: 10.1007/s11657-014-0187-y. Epub 2014 Jun 27. Arch Osteoporos. 2014. PMID: 24970672 Review. - Current and future economic burden of osteoporosis in New Zealand.
Brown P, McNeill R, Leung W, Radwan E, Willingale J. Brown P, et al. Appl Health Econ Health Policy. 2011 Mar 1;9(2):111-23. doi: 10.2165/11531500-000000000-00000. Appl Health Econ Health Policy. 2011. PMID: 21271750 - Fragility fractures in Europe: burden, management and opportunities.
Borgström F, Karlsson L, Ortsäter G, Norton N, Halbout P, Cooper C, Lorentzon M, McCloskey EV, Harvey NC, Javaid MK, Kanis JA; International Osteoporosis Foundation. Borgström F, et al. Arch Osteoporos. 2020 Apr 19;15(1):59. doi: 10.1007/s11657-020-0706-y. Arch Osteoporos. 2020. PMID: 32306163 Free PMC article. - SCOPE: a scorecard for osteoporosis in Europe.
Kanis JA, Borgström F, Compston J, Dreinhöfer K, Nolte E, Jonsson L, Lems WF, McCloskey EV, Rizzoli R, Stenmark J. Kanis JA, et al. Arch Osteoporos. 2013;8(1):144. doi: 10.1007/s11657-013-0144-1. Epub 2013 Sep 13. Arch Osteoporos. 2013. PMID: 24030479 Free PMC article.
Cited by
- [Geriatric traumatological management of osteoporosis : "Let the first fracture be the last"].
Buehring B, Maus U. Buehring B, et al. Z Gerontol Geriatr. 2024 Oct 7. doi: 10.1007/s00391-024-02370-9. Online ahead of print. Z Gerontol Geriatr. 2024. PMID: 39373920 Review. German. - Prevalence of fractures in adults over 50 years of age with osteoporosis in Colombia.
Correa-Gonzalez N, Fernández-Ávila DG, Rosselli D. Correa-Gonzalez N, et al. Arch Osteoporos. 2024 Sep 27;19(1):92. doi: 10.1007/s11657-024-01412-4. Arch Osteoporos. 2024. PMID: 39331251 - The Orthopedic Upper Extremity Surgeon's Role in the Diagnosis and Treatment of Osteoporosis: Making Use of Opportunistic Imaging.
Ward CM, Gullborg EJ, Simcock XC. Ward CM, et al. J Clin Med. 2024 Aug 28;13(17):5095. doi: 10.3390/jcm13175095. J Clin Med. 2024. PMID: 39274308 Free PMC article. Review. - Research trends and hotspots on osteoporosis: a decade-long bibliometric and visualization analysis from 2014 to 2023.
Zhang S, Liu Y, Yu W, Gu X. Zhang S, et al. Front Med (Lausanne). 2024 Aug 29;11:1436486. doi: 10.3389/fmed.2024.1436486. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39267978 Free PMC article. - Osteoarthritic Bony Alterations of Temporomandibular Joint and Relation to Low Bone Mineral Density in Postmenopausal Edentulous Females.
Krumpane L, Nikitina E, Neimane L, Abeltins A, Soboleva U, Slaidina A. Krumpane L, et al. Dent J (Basel). 2024 Jul 26;12(8):238. doi: 10.3390/dj12080238. Dent J (Basel). 2024. PMID: 39195082 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous